Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pimodivir on Pitavastatin PK in Healthy Subjects
NCT02595268Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pimodivir in Influenza A (IAV), sponsored by Janssen Pharmaceutical. Primary endpoints: Observed Analyte Concentration Just Prior to the Beginning or at the End of a Dosing Interval (Ctrough) of JNJ-63623872 at Day 9, Minimum Observed Analyte Concentration (Cmin) of JNJ-63623872 at Day 9 and 15 more. Started Nov 2015; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02595268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595268.